Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
The Changing Landscape in Mantle Cell Lymphoma
EP. 1: Incidence and Clinical Presentation of MCL
January 30th 2020
EP. 2: Biomarkers in Mantle Cell Lymphoma Pathogenesis
January 30th 2020
EP. 3: Clinical Workup for Mantle Cell Lymphoma
January 30th 2020
EP. 4: Prognostic Indicators for Mantle Cell Lymphoma
January 30th 2020
EP. 5: Frontline Therapy for Mantle Cell Lymphoma
January 30th 2020
EP. 6: Changing Treatment Landscape for R/R MCL
January 30th 2020
EP. 7: Recent Approval of Zanubrutinib for R/R MCL
January 30th 2020
EP. 8: Acalabrutinib in R/R MCL
January 30th 2020
EP. 9: Treatment Challenges for R/R MCL
January 30th 2020
EP. 10: Ibrutinib in R/R MCL
January 30th 2020
EP. 11: Recent FDA Approvals in MCL
January 30th 2020
EP. 12: Differences Among BTK Inhibitors for MCL
January 30th 2020
EP. 13: Patient Selection Among FDA Approved BTK Inhibitors
January 30th 2020
EP. 14: Challenges in Treating R/R MCL
January 30th 2020
EP. 15: CAR T-Cell Therapy for MCL
January 30th 2020
EP. 16: Noteworthy Data on MCL: ASH 2019
January 30th 2020
EP. 17: Emerging Treatments in MCL
January 30th 2020
EP. 18: Emerging KTE-X19 CAR T-Cell Therapy for MCL
January 30th 2020
EP. 19: Final Thoughts From ASH 2019 on MCL
January 30th 2020